The Importance of Finding the Top Mesothelioma Doctors for Treatment

If you’ve been diagnosed with mesothelioma it is very important that you have access to the top mesothelioma doctors. It is one of our goals at to provide you with the information needed to make the correct decision when it comes to the treatment of this disease.


Although we have listed some of the top mesothelioma doctors, it is important that you contact us for even more doctors but also, we can help you find the best mesothelioma doctor for you based on your specific location, diagnosis and situation. This will help assure you of the best treatment in your unique situation.

Dr. Rodney Landreneau, MD

Rodney J. Landreneau, MD is board-certified in thoracic surgery (thoracic and cardiovascular surgery). He is a native of south Louisiana where he received an undergraduate degree from Louisiana State University in Baton Rouge.

He then completed his medical education at Louisiana State University Medical School in New Orleans where he graduated with honors and was elected to the Alpha Omega Alpha medical honor society. Dr. Landreneau completed residency in general surgery at the University of Texas-Southwestern Medical Center in Dallas, Texas, and completed residency in thoracic surgery at the Unviersity of Michigan, Ann Arbor.

Dr. Landreneau is a member of numerous professional organizations, including the American Surgical Association, the American Association for Thoracic Surgery, the Amercian College of Chest Physicians, the Society of Surgical Oncology, and the American Society of Clinical Oncology. Dr. Landreneau has authored more than 350 scientific peer reviewed clinical journal articles on minimally invasive surgery, lung cancer, and other thoracic oncologic topics.

He is a leading thoracic oncologic clinical investigator with the American College of Surgeons Oncology Group (ACOSOG) and he is presently a leading member of the “Alliance” Cancer Cooperative Group which is the amalgamation of the previous national cancer groups (ACOSOG, CAL-GB and NCCTG).

Clinical Interests
Dr. Landreneau’s areas of clinical interests include minimally invasive surgery, video-assisted thoracic surgery, lung cancer surgery/treatment, surgical treatment of esophageal cancer and benign esophageal conditions such as gastroesophageal reflux and achalasia. Dr. Landreneau has extensive experience in the management of mesothelioma of the lung and the surgical treatment of mediastinal conditions such as myasthenia gravis and mediatinal malignancies


Dr. Jacques P. Fontaine, MD

Dr. Jacques Fontaine is the lead thoracic surgeon of the Moffitt Cancer Center – Mesothelioma Research and Treatment Center. He is an Associate Professor of Surgery at University of South Florida.

He is board-certified by the American Board of Thoracic Surgery and the American Board of Surgery. He is also a Fellow of the Royal College of Surgeons of Canada as well as the American College of Surgeons.

Dr Fontaine was born in Montreal, Canada to Lebanese parents. Having been raised in several different countries, he was fortunate enough to become fluent in English, French, Spanish and Arabic. He is an avid traveler and enjoys skiing, scuba diving and cooking.

He received his medical degree from McGill University in Montreal. Upon completing his general surgery residency at Boston University, he returned to Canada and participated in a government program to serve as surgeon for a year in a remote rural region of Newfoundland. He then returned to Boston, and in 2006, graduated as chief resident in thoracic surgery at Brigham and Women’s Hospital – Harvard Medical School.

Dr. Fontaine began his thoracic surgery practice in 2006 at the University of Montreal. He was then recruited to become part of the Department of Thoracic Surgery at Brown Medical School in Providence, RI. He was in charge of developing a thoracic surgery program at one of Brown University’s teaching hospitals. In 2011, Dr. Fontaine joined the H. Lee Moffitt Cancer Center as full-time associate member of the Departments of Thoracic & GI Oncology. He also holds an appointment as Associate Professor of Surgery at the University of South Florida College of Medicine.

Dr. Fontaine has a keen interest in mesothelioma, thymoma, lung and esophageal cancers. He has developed an expertise in minimally invasive techniques including robotic surgery for malignant diseases of the chest. A firm believer in the multidisciplinary approach and translational research, he continues to participate actively in clinical research projects and surgical outcome initiatives.

The development cycle of this form of cancer is generally divided into 4 stages. During the first stage it is limited to the area of origin and no lymph nodes are affected. In stage 2 it spreads to the lymph nodes but is still mostly confined. In the third stage it spreads beyond the point of origin and in stage four, the most serious point, it has affected other organs and almost all lymph nodes.


Fontaine Jacques-Pierre

Dr. Marcelo DaSilva, M.D., FACS, FCCP

Dr. Marcelo DaSilva is the Chief of Thoracic Surgery at Loyola University Medical Center in Chicago. He is triple board certified in thoracic, cardiovascular and critical care and surgery. Prior to joining Loyola University, Dr. DaSilva was a thoracic surgeon at the Brigham and Women’s Hospital and Instructor in Surgery at Harvard Medical School. He also served as a consultant at the Dana Farber Cancer Institute in Boston.

He has been involved in the treatment of malignant pleural mesothelioma with heated-intraoperative chemotherapy (HIOC) and thermoablation techniques since 2008. Dr DaSilva is a member of the International Association for the Study of Lung Cancer (IASLC), the International Society of Heart & Lung Transplantation, and Society of Thoracic Surgery.

He is a Fellow of the American College of Surgeons, Fellow of the American College of Chest Physician, Fellow of the International College of Surgeons, an active member of the European Society of Thoracic Surgery, Association for Academic Surgery, Society of Critical Care Medicine, and Massachusetts Medical Society.

He is the elected President of the Illinois Thoracic Surgery Society. Dr. Marcelo DaSilva is the program director for the International Midwest Mesothelioma Program (iMMP) as well as the Co-Director of the Lung Cancer Center at the Cardinal Bernadine Cancer Center. He has a dual appointment with the departments of thoracic-cardiovascular surgery and general surgery at the Stritch School of Medicine, Loyola University Medical Center, Chicago.

If you would like to contact Dr. Marcelo DaSilva, please call his appointment line at 708-CAN-HELP (226-4357)


Dr. Marcelo DaSilva, M.D., FACS, FCCP

Dr. Raffit Hassan, M.D.

Dr. Hassan is a medical oncologist and senior investigator at the National Cancer Institute (NCI). Dr. Hassan has focused on developing novel therapies for the treatment of malignant mesothelioma. He is currently conducting clinical trials of two different immunotherapy agents targeting the tumor antigen mesothelin, which was discovered at NCI. Dr. Hassan is the chairman of the Science Advisory Board of the Meso Foundation. He is a recipient of the American Society of Clinical Oncology Career Development Award as well as the National Institutes of Health K23 Career Development Award.


Dr. Raffit Hassan, M.D.

Dr. Paul Sugarbaker, M.D.

Paul Sugarbaker, MD is a mentor, investigator, and has lectured extensively, both nationally and internationally, earning numerous awards and citations. He is best known for his expertise in gastrointestinal oncology and colorectal cancer surgery and in rare diseases such as pseudomyxoma peritonei, peritoneal mesothelioma, abdominal sarcomas, and peritoneal carcinomatosis. Dr. Sugarbaker has pioneered specialty treatment procedures such as cytoreductive surgery with heated intraoperative intraperitoneal chemotherapy and hyperthermia treatments using the Thermotron RF-8. He has published more than 780 scientific articles in peer-reviewed journals, numerous book chapters and textbooks. The textbook on sarcoma surgery has been translated into 5 languages.


Dr. Paul Sugarbaker, M.D.

Dr. Tawee Tanvetyanon, M.D.

Dr. Tanvetyanon is a medical oncologist and his expertises include chemotherapy for both pleural, peritoneal or pericardial mesothelioma. He is an Associate Professor of Oncologic Sciences at the University of South Florida at Moffitt Cancer Center, Tampa. Dr. Tanvetyanon coordinates and uses hypertherminc intraperitoneal chemotherapy. He offers several novel treatments through clinical trials. He has published numerous research articles on patient survival and outcomes.


Dr Tawee Tanvetyanon

Dr. Eric Vallieres, M.D.

Dr. Vallieres is the Surgical Director of the Lung Cancer Program at Swedish Medical Center in Seattle, Washington. His research focuses on induction chemotherapy in the treatment of surgical lung cancer, with specialties in mesothelioma, as well as bronchoscopy, chest wall tumors, esophageal achalasia and hyperhidrosis. Dr. Vallieres received his medical degree from the Université Laval in Quebec. He then completed a residency at the University of Toronto, and a fellowship under Professor Louis Couraud in Bordeaux, France.


Dr Eric Vallieres